Skip to content Carb-X
Carb-X
Boston University
Mobile Menu Toggle navigation
  • Contact
  • Twitter
  • LinkedIn
Carb-X
Boston University
Boston University
  • About CARB-X
    • Overview
    • Global Threat
    • Our Strategy
    • Stewardship and Access
    • Management & Staff
    • Joint Oversight Committee
    • Advisory Board
    • Careers
    • Annual Reports
    • Boston University
  • Portfolio
    • Portfolio-Product Developers
    • Portfolio-Pipeline
    • CARB-X Graduates
    • Spotlight on Science
    • Portfolio Acceleration Tools
  • Partners
    • Funding Partners
    • Global Accelerator Network
  • Apply
    • Application Process
    • The CARB-X Process
    • Official Development Assistance
    • Research Compliance
    • Additional Information and Resources
    • Apply Here
  • Resources
    • Presentations
    • Videos
    • Publications
    • Education
    • PD Resources
  • News
    • CARB-X News
    • In the News
    • Antibiotic Resistance
    • Media Resources
  • Events
  • About CARB-X
    • Overview
    • Global Threat
    • Our Strategy
    • Stewardship and Access
    • Management & Staff
    • Joint Oversight Committee
    • Advisory Board
    • Careers
    • Annual Reports
    • Boston University
  • Portfolio
    • Portfolio-Product Developers
    • CARB-X Graduates
    • Spotlight on Science
  • Partners
    • Funding Partners
    • Global Accelerator Network
  • Apply
    • Application Process
    • The CARB-X Process
    • Official Development Assistance
    • Research Compliance
    • Additional Information and Resources
    • Apply Here
  • Resources
    • Presentations
    • Videos
    • Publications
    • Education
    • PD Resources
  • News
    • CARB-X News
    • In the News
    • Antibiotic Resistance
    • Media Resources
  • Events
  • Contact
  • Legal

Boston University

  • About CARB-X
  • >
  • Boston University

Boston University

Boston University (BU) is the home of CARB-X and the heart of its operations. Based at the BU School of Law, CARB-X is an example of BU’s leadership, collaboration, and engagement with the larger world: a global partnership confronting a dire public health threat – antibiotic-resistant bacteria. Led by Executive Director Kevin Outterson, N. Neal Pike Scholar in Health and Disability Law at the School of Law, the program facilitates the creation of new vaccines, diagnostics, and therapies around the world to stop the spread of disease – a goal with increasing urgency.

And BU has the expertise to achieve it. A major global research university, BU is a member of the prestigious Association of American Universities. BU’s transformative, cutting-edge research – sponsored annually by hundreds of millions of dollars in awards – addresses society’s most pressing challenges.

“CARB-X’s innovative approach has the best potential to solve the enormous human health problem of increasing resistance to drugs used to treat bacterial infections.”

— Robert A. Brown, President, Boston University

Carb-X

Led by Boston University

Copyright 2022

  • Contact
  • Careers
  • Site Credits
  • Legal
  • Twitter
  • LinkedIn

Copyright 2022